Differential gene expression profiles in salicylate ototoxicity of the mouse

Gi Jung Im, Hak Hyun Jung, Sungwon Chae, Woo Sung Cho, Seo Jin Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Conclusion. This study demonstrated differential gene expression profiles in salicylate ototoxicity with oligonucleotide microarray. This study may also provide basic information on candidate genes associated with hearing loss and/or tinnitus or recovery after salicylate-induced cochlear dysfunction. Objectives: Salicylate ototoxicity is accompanied by temporary hearing loss and tinnitus. The purpose of the present study was to evaluate the gene expression profiles in the mouse cochlea with salicylate ototoxicity using DNA microarray. Materials and methods: The subject mice were injected intraperitoneally with 400 mg/kg of sodium salicylate; an approximate 30 dB threshold shift that was observed by auditory brainstem response was achieved 3 h after an injection of sodium salicylate and the hearing threshold returned to within normal range at 3 days. Differential gene expression profiles at 3 h after salicylate injection in comparison to the normal cochlea were analyzed with DNA microarray technology. Results: No ultrastructural changes in the mice cochlea were observed by TEM at 3 h after salicylate injection. Microarray revealed that 87 genes were up-regulated twofold or more in the mouse cochlea with salicylate ototoxicity in comparison to the normal cochlea. Among these genes, increased expression levels of 30 functional genes were confirmed by semi-quantitative RT-PCR.

Original languageEnglish
Pages (from-to)459-469
Number of pages11
JournalActa Oto-Laryngologica
Volume127
Issue number5
DOIs
Publication statusPublished - 2007 Apr 27

Fingerprint

Salicylates
Transcriptome
Cochlea
Oligonucleotide Array Sequence Analysis
Sodium Salicylate
Tinnitus
Hearing Loss
Injections
Genes
Brain Stem Auditory Evoked Potentials
Hearing
Reference Values
Technology
Gene Expression
Polymerase Chain Reaction

Keywords

  • Cochlea
  • Mouse
  • Ototoxicity
  • Salicylate

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Differential gene expression profiles in salicylate ototoxicity of the mouse. / Im, Gi Jung; Jung, Hak Hyun; Chae, Sungwon; Cho, Woo Sung; Kim, Seo Jin.

In: Acta Oto-Laryngologica, Vol. 127, No. 5, 27.04.2007, p. 459-469.

Research output: Contribution to journalArticle

@article{43e10fee875c4330b44e96d1dc1417de,
title = "Differential gene expression profiles in salicylate ototoxicity of the mouse",
abstract = "Conclusion. This study demonstrated differential gene expression profiles in salicylate ototoxicity with oligonucleotide microarray. This study may also provide basic information on candidate genes associated with hearing loss and/or tinnitus or recovery after salicylate-induced cochlear dysfunction. Objectives: Salicylate ototoxicity is accompanied by temporary hearing loss and tinnitus. The purpose of the present study was to evaluate the gene expression profiles in the mouse cochlea with salicylate ototoxicity using DNA microarray. Materials and methods: The subject mice were injected intraperitoneally with 400 mg/kg of sodium salicylate; an approximate 30 dB threshold shift that was observed by auditory brainstem response was achieved 3 h after an injection of sodium salicylate and the hearing threshold returned to within normal range at 3 days. Differential gene expression profiles at 3 h after salicylate injection in comparison to the normal cochlea were analyzed with DNA microarray technology. Results: No ultrastructural changes in the mice cochlea were observed by TEM at 3 h after salicylate injection. Microarray revealed that 87 genes were up-regulated twofold or more in the mouse cochlea with salicylate ototoxicity in comparison to the normal cochlea. Among these genes, increased expression levels of 30 functional genes were confirmed by semi-quantitative RT-PCR.",
keywords = "Cochlea, Mouse, Ototoxicity, Salicylate",
author = "Im, {Gi Jung} and Jung, {Hak Hyun} and Sungwon Chae and Cho, {Woo Sung} and Kim, {Seo Jin}",
year = "2007",
month = "4",
day = "27",
doi = "10.1080/00016480600801365",
language = "English",
volume = "127",
pages = "459--469",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Differential gene expression profiles in salicylate ototoxicity of the mouse

AU - Im, Gi Jung

AU - Jung, Hak Hyun

AU - Chae, Sungwon

AU - Cho, Woo Sung

AU - Kim, Seo Jin

PY - 2007/4/27

Y1 - 2007/4/27

N2 - Conclusion. This study demonstrated differential gene expression profiles in salicylate ototoxicity with oligonucleotide microarray. This study may also provide basic information on candidate genes associated with hearing loss and/or tinnitus or recovery after salicylate-induced cochlear dysfunction. Objectives: Salicylate ototoxicity is accompanied by temporary hearing loss and tinnitus. The purpose of the present study was to evaluate the gene expression profiles in the mouse cochlea with salicylate ototoxicity using DNA microarray. Materials and methods: The subject mice were injected intraperitoneally with 400 mg/kg of sodium salicylate; an approximate 30 dB threshold shift that was observed by auditory brainstem response was achieved 3 h after an injection of sodium salicylate and the hearing threshold returned to within normal range at 3 days. Differential gene expression profiles at 3 h after salicylate injection in comparison to the normal cochlea were analyzed with DNA microarray technology. Results: No ultrastructural changes in the mice cochlea were observed by TEM at 3 h after salicylate injection. Microarray revealed that 87 genes were up-regulated twofold or more in the mouse cochlea with salicylate ototoxicity in comparison to the normal cochlea. Among these genes, increased expression levels of 30 functional genes were confirmed by semi-quantitative RT-PCR.

AB - Conclusion. This study demonstrated differential gene expression profiles in salicylate ototoxicity with oligonucleotide microarray. This study may also provide basic information on candidate genes associated with hearing loss and/or tinnitus or recovery after salicylate-induced cochlear dysfunction. Objectives: Salicylate ototoxicity is accompanied by temporary hearing loss and tinnitus. The purpose of the present study was to evaluate the gene expression profiles in the mouse cochlea with salicylate ototoxicity using DNA microarray. Materials and methods: The subject mice were injected intraperitoneally with 400 mg/kg of sodium salicylate; an approximate 30 dB threshold shift that was observed by auditory brainstem response was achieved 3 h after an injection of sodium salicylate and the hearing threshold returned to within normal range at 3 days. Differential gene expression profiles at 3 h after salicylate injection in comparison to the normal cochlea were analyzed with DNA microarray technology. Results: No ultrastructural changes in the mice cochlea were observed by TEM at 3 h after salicylate injection. Microarray revealed that 87 genes were up-regulated twofold or more in the mouse cochlea with salicylate ototoxicity in comparison to the normal cochlea. Among these genes, increased expression levels of 30 functional genes were confirmed by semi-quantitative RT-PCR.

KW - Cochlea

KW - Mouse

KW - Ototoxicity

KW - Salicylate

UR - http://www.scopus.com/inward/record.url?scp=34247399966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247399966&partnerID=8YFLogxK

U2 - 10.1080/00016480600801365

DO - 10.1080/00016480600801365

M3 - Article

VL - 127

SP - 459

EP - 469

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 5

ER -